These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

132 related items for PubMed ID: 10463426

  • 1. Control of cytomegalovirus retinitis after combination antiretroviral therapy.
    Ruhswurm I, Ries E, Krepler K, Derbolav A, Rieger A, Armbruster C, Wedrich A.
    Acta Ophthalmol Scand; 1999 Aug; 77(4):471-3. PubMed ID: 10463426
    [Abstract] [Full Text] [Related]

  • 2. Cytomegalovirus retinitis after initiation of highly active antiretroviral therapy.
    Jacobson MA, Zegans M, Pavan PR, O'Donnell JJ, Sattler F, Rao N, Owens S, Pollard R.
    Lancet; 1997 May 17; 349(9063):1443-5. PubMed ID: 9164318
    [Abstract] [Full Text] [Related]

  • 3. Cytomegalovirus retinitis in advanced HIV-infected patients treated with protease inhibitors: incidence and outcome over 2 years.
    Labetoulle M, Goujard C, Frau E, Rogier H, Niessen F, Furlan V, Lantz O, Lecointe D, Delfraissy JF, Offret H.
    J Acquir Immune Defic Syndr; 1999 Nov 01; 22(3):228-34. PubMed ID: 10770342
    [Abstract] [Full Text] [Related]

  • 4. Cytomegalovirus retinitis in the era of highly active antiretroviral therapy.
    Whitcup SM.
    JAMA; 2000 Feb 02; 283(5):653-7. PubMed ID: 10665706
    [Abstract] [Full Text] [Related]

  • 5. Long-lasting remission of cytomegalovirus retinitis without maintenance therapy in human immunodeficiency virus-infected patients.
    Tural C, Romeu J, Sirera G, Andreu D, Conejero M, Ruiz S, Jou A, Bonjoch A, Ruiz L, Arnó A, Clotet B.
    J Infect Dis; 1998 Apr 02; 177(4):1080-3. PubMed ID: 9534987
    [Abstract] [Full Text] [Related]

  • 6. Discontinuation of anticytomegalovirus therapy in patients with HIV infection and cytomegalovirus retinitis.
    Whitcup SM, Fortin E, Lindblad AS, Griffiths P, Metcalf JA, Robinson MR, Manischewitz J, Baird B, Perry C, Kidd IM, Vrabec T, Davey RT, Falloon J, Walker RE, Kovacs JA, Lane HC, Nussenblatt RB, Smith J, Masur H, Polis MA.
    JAMA; 1999 Nov 03; 282(17):1633-7. PubMed ID: 10553789
    [Abstract] [Full Text] [Related]

  • 7. High-dose (5000-microg) intravitreal ganciclovir combined with highly active antiretroviral therapy for cytomegalovirus retinitis in HIV-infected patients in Venezuela.
    Arevalo JF, Garcia RA, Mendoza AJ.
    Eur J Ophthalmol; 2005 Nov 03; 15(5):610-8. PubMed ID: 16167292
    [Abstract] [Full Text] [Related]

  • 8. Discontinuation of maintenance therapy for cytomegalovirus retinitis in HIV-infected patients receiving highly active antiretroviral therapy.
    Jouan M, Savès M, Tubiana R, Carcelain G, Cassoux N, Aubron-Olivier C, Fillet AM, Nciri M, Sénéchal B, Chêne G, Tural C, Lasry S, Autran B, Katlama C, RESTIMOP study team.
    AIDS; 2001 Jan 05; 15(1):23-31. PubMed ID: 11192865
    [Abstract] [Full Text] [Related]

  • 9. Nonprogressive CMV retinitis in AIDS patients with protease inhibitors therapy for AIDS.
    Ortega-Larrocea G, Feregrino-Goyos M.
    Ocul Immunol Inflamm; 1997 Dec 05; 5(4):279-82. PubMed ID: 9455745
    [Abstract] [Full Text] [Related]

  • 10. Highly active antiretroviral therapy-related immune recovery in AIDS patients with cytomegalovirus retinitis.
    Macdonald JC, Karavellas MP, Torriani FJ, Morse LS, Smith IL, Reed JB, Freeman WR.
    Ophthalmology; 2000 May 05; 107(5):877-81; discussion 881-3. PubMed ID: 10811078
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. CMV retinitis recurs after stopping treatment in virological and immunological failures of potent antiretroviral therapy.
    Torriani FJ, Freeman WR, Macdonald JC, Karavellas MP, Durand DM, Jeffrey DD, Meylan PR, Schrier RD.
    AIDS; 2000 Jan 28; 14(2):173-80. PubMed ID: 10708288
    [Abstract] [Full Text] [Related]

  • 13. Characterization of reactivation of cytomegalovirus retinitis in patients healed after treatment with highly active antiretroviral therapy.
    Song MK, Karavellas MP, MacDonald JC, Plummer DJ, Freeman WR.
    Retina; 2000 Jan 28; 20(2):151-5. PubMed ID: 10783947
    [Abstract] [Full Text] [Related]

  • 14. Cytomegalovirus retinitis after the initiation of highly active antiretroviral therapy: a 2 year prospective study.
    Mitchell SM, Membrey WL, Youle MS, Obi A, Worrell S, Gazzard BG.
    Br J Ophthalmol; 1999 Jun 28; 83(6):652-5. PubMed ID: 10340970
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Loss of cytomegalovirus (CMV) viraemia following highly active antiretroviral therapy in the absence of specific anti-CMV therapy.
    Deayton J, Mocroft A, Wilson P, Emery VC, Johnson MA, Griffiths PD.
    AIDS; 1999 Jul 09; 13(10):1203-6. PubMed ID: 10416523
    [Abstract] [Full Text] [Related]

  • 18. Highly active antiretroviral therapy-associated regression of cytomegalovirus retinitis: long-Term results in a small case series.
    Reed JB, Briggs JW, McDonald JC, Freeman WR, Morse LS.
    Retina; 2001 Jul 09; 21(4):339-43. PubMed ID: 11508879
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Characteristics of untreated AIDS-related cytomegalovirus retinitis. II. Findings in the era of highly active antiretroviral therapy (1997 to 2000).
    Holland GN, Vaudaux JD, Shiramizu KM, Yu F, Goldenberg DT, Gupta A, Carlson M, Read RW, Novack RD, Kuppermann BD, Southern California HIV/Eye Consortium.
    Am J Ophthalmol; 2008 Jan 09; 145(1):12-22. PubMed ID: 18154751
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.